Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$509K Sell
3,640
-603
-14% -$76.3K 0.04% 220
2026
Q1
$457K Buy
4,243
+231
+6% +$26K 0.04% 276
2025
Q4
$453K Buy
4,012
+1,107
+38% +$106K 0.04% 252
2025
Q3
$237K Buy
2,905
+750
+35% +$68.9K 0.02% 427
2025
Q2
$223K Sell
2,155
-844
-28% -$79.2K 0.02% 362
2025
Q1
$295K Sell
2,999
-3,481
-54% -$464K 0.03% 344
2024
Q4
$972K Sell
6,480
-4,863
-43% -$670K 0.07% 164
2024
Q3
$1.48M Buy
11,343
+386
+4% +$48K 0.11% 101
2024
Q2
$1.3M Buy
10,957
+208
+2% +$22.1K 0.1% 102
2024
Q1
$1.01M Buy
10,749
+3,761
+54% +$336K 0.08% 160
2023
Q4
$555K Buy
+6,988
New +$476K 0.05% 249

Other funds holding GKOS

Trust Point Inc's GKOS Position: Q2 2026 in Review

Trust Point Inc reduced its Glaukos (GKOS) stake by 14% in Q2 2026, selling an estimated $76.3K and leaving 3,640 shares worth $509K. The position accounts for 0.04% of the portfolio, ranked #220.

Trust Point Inc first reported a position in GKOS in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.48M in Q3 2024. 365 funds tracked by Wall St. Rank hold GKOS as of Q2 2026.

  • Trust Point Inc held 3,640 shares of Glaukos worth $509K as of Q2 2026.
  • Trust Point Inc sold 603 Glaukos shares in Q2 2026, an estimated $76.3K.
  • Glaukos made up 0.04% of Trust Point Inc's portfolio in Q2 2026, its #220 holding.
  • Trust Point Inc first reported a position in Glaukos in Q4 2023 and has held it in 11 quarters since.
  • Trust Point Inc's Glaukos position peaked at $1.48M in Q3 2024.
  • 365 funds tracked by Wall St. Rank held Glaukos as of Q2 2026.

Based on Trust Point Inc's 13F filing for Q2 2026, filed 8 Jul 2026.